Bharat Biotech seeks DCGI nod for phase 2/3 Covaxin booster trial among two to 18-year-old, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

The study is likely to be conducted at six sites, including AIIMS Delhi and Patna. India began administering precaution doses of vaccines to the healthcare and frontline workers and those aged 60 and above with comorbidities on January 10 this year., The study is likely to be conducted at six sites, including AIIMS Delhi and Patna. India began administering precaution doses of vaccines to the healthcare and frontline workers and those aged 60 and above with comorbidities on January 10 this year., , Read More

Leave a Reply

Your email address will not be published. Required fields are marked *